NCT02737020

Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Hospital de Clinicas de Porto Alegre · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study evaluates the use of Rhodiola rosea in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) in adults. Half of participants will receive Rhodiola rosea, while the other half will receive placebo.

Detailed description

Rhodiola rosea is an herbal medicine used for centuries in various medical conditions. Many randomized controlled trials have evaluated its usefulness in stress and fatigue. There were benefits in attention in some of these studies. Mild side effects and beneficial antioxidant properties make reasonable an assessment of its potential benefits in adults with ADHD. To our knowledge, Rhodiola rosea was never studied in ADHD.

Conditions

• Attention Deficit/Hyperactivity Disorder

Interventions

Type	Name	Description
DRUG	Rhodiola	Rhodiola rosea 200mg pill up to four times a day
DRUG	Placebo	up to four times a day

Timeline

• Start date: 2016-04-01
• Primary completion: 2021-03-01
• Completion: 2021-03-01
• First posted: 2016-04-13
• Last updated: 2019-05-29

Locations

1 site across 1 country: Brazil